Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
732.5 CHF | -0.34% | 0.00% | +7.56% |
May. 09 | Berenberg Lifts Price Target on EMS-Chemie, Maintains Hold Recommendation | MT |
Apr. 25 | EMS-Chemie Q1 Net Sales Decline | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 38.55 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.56% | 19.22B | C+ | ||
+21.02% | 68.55B | A- | ||
-6.50% | 46.06B | A- | ||
+23.31% | 44.48B | B+ | ||
+31.85% | 28.5B | A- | ||
+12.81% | 16.8B | B+ | ||
-23.96% | 15.27B | A- | ||
-10.29% | 15.22B | B+ | ||
-28.36% | 12.17B | C+ | ||
-29.56% | 12.12B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- EMSN Stock
- Ratings EMS-CHEMIE HOLDING AG